SSI Diagnostica Group

Gold Sponsor

SSI Diagnostica Group is a global company with ~600 employees, specializing in infectious disease solutions across gastrointestinal, respiratory, and bloodborne—including tropical—diseases. With more than a century of continuous microbiology and serology expertise, we provide trusted support across three key application areas: vaccine development, disease surveillance, and diagnostic testing.

Our solutions enable accurate pathogen characterization, vaccine identity and potency assessment, assay design, and robust analytical workflows across key pathogens such as

• Pneumococcus
• Influenza virus
• Salmonella
• E. coli
• C. difficile
• Dengue virus
• …and more

Our portfolio at a glance:

• Reagents: strains, antigens, antisera/antibodies
• Ready‑to‑use antisera for nephelometry assays
• Multiplexing solutions for vaccine antigens, serology, and mRNA analytics
• IVD product portfolio

We offer off‑the‑shelf solutions, OEM options, and customizations, giving laboratories the analytical flexibility they need.

Learn more about our offering in the vaccine segment here.

In February 2026, InDevR joined SSI Diagnostica Group, strengthening our capabilities with advanced multiplexed analytical platforms that accelerate vaccine development and enhance quality control across conventional, viral, and mRNA technologies.

Both SSI Diagnostica Group and InDevR representatives will be available at our booth to explore how our unified portfolio supports your infectious disease work with the disease expertise, flexibility, and trusted partnership that define our approach.

website